{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:04:10Z","timestamp":1794330250696,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070130"],"award-info":[{"award-number":["82070130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12185-023-03684-x","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T15:02:26Z","timestamp":1703602946000},"page":"119-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["SPAG6 regulates cell proliferation and apoptosis via TGF-\u03b2\/Smad signal pathway in adult B-cell acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"119","author":[{"given":"Beibei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5496-5287","authenticated-orcid":false,"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"issue":"1","key":"3684_CR1","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1038\/s41467-022-31818-y","volume":"13","author":"M Cort\u00e9s-L\u00f3pez","year":"2022","unstructured":"Cort\u00e9s-L\u00f3pez M, Schulz L, Enculescu M, Paret C, Spiekermann B, Quesnel-Valli\u00e8res M, et al. High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance. Nat Commun. 2022;13(1):5570. https:\/\/doi.org\/10.1038\/s41467-022-31818-y.","journal-title":"Nat Commun"},{"issue":"15","key":"3684_CR2","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/cncr.29383","volume":"121","author":"E Jabbour","year":"2015","unstructured":"Jabbour E, O\u2019Brien S, Konopleva M, Kantarjian H. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer. 2015;121(15):2517\u201328. https:\/\/doi.org\/10.1002\/cncr.29383.","journal-title":"Cancer"},{"issue":"10230","key":"3684_CR3","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/s0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet (London, England). 2020;395(10230):1146\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(19)33018-1.","journal-title":"Lancet (London, England)"},{"issue":"12","key":"3684_CR4","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","volume":"106","author":"JM Rowe","year":"2005","unstructured":"Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM, et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993. Blood. 2005;106(12):3760\u20137. https:\/\/doi.org\/10.1182\/blood-2005-04-1623.","journal-title":"Blood"},{"issue":"7","key":"3684_CR5","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2008-06-164863","volume":"113","author":"D Pulte","year":"2009","unstructured":"Pulte D, Gondos A, Brenner H. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood. 2009;113(7):1408\u201311. https:\/\/doi.org\/10.1182\/blood-2008-06-164863.","journal-title":"Blood"},{"issue":"1","key":"3684_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1182\/blood-2014-01-549352","volume":"124","author":"B Patel","year":"2014","unstructured":"Patel B, Dey A, Castleton AZ, Schwab C, Samuel E, Sivakumaran J, et al. Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology. Blood. 2014;124(1):96\u2013105. https:\/\/doi.org\/10.1182\/blood-2014-01-549352.","journal-title":"Blood"},{"issue":"5","key":"3684_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1200\/jco.2010.30.1382","volume":"29","author":"R Bassan","year":"2011","unstructured":"Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol: off J Am Soc Clin Oncol. 2011;29(5):532\u201343. https:\/\/doi.org\/10.1200\/jco.2010.30.1382.","journal-title":"J Clin Oncol: off J Am Soc Clin Oncol"},{"issue":"8","key":"3684_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrc1669","volume":"5","author":"AJ Simpson","year":"2005","unstructured":"Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer\/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5(8):615\u201325. https:\/\/doi.org\/10.1038\/nrc1669.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3684_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/CJI.0b013e3181fb64fa","volume":"34","author":"K Sili\u0146a","year":"2011","unstructured":"Sili\u0146a K, Zayakin P, Kalni\u0146a Z, Ivanova L, Meistere I, Endzeli\u0146\u0161 E, et al. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients. J Immunother (Hagerstown, Md: 1997). 2011;34(1):28\u201344. https:\/\/doi.org\/10.1097\/CJI.0b013e3181fb64fa.","journal-title":"J Immunother (Hagerstown, Md: 1997)"},{"issue":"17","key":"3684_CR10","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1158\/1078-0432.Ccr-09-0737","volume":"15","author":"MA Cheever","year":"2009","unstructured":"Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res: An Off J Am Assoc Cancer Res. 2009;15(17):5323\u201337. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-09-0737.","journal-title":"Clin Cancer Res: An Off J Am Assoc Cancer Res"},{"issue":"6","key":"3684_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/ijc.11292","volume":"106","author":"E J\u00e4ger","year":"2003","unstructured":"J\u00e4ger E, J\u00e4ger D, Knuth A. Antigen-specific immunotherapy and cancer vaccines. Int J Cancer. 2003;106(6):817\u201320. https:\/\/doi.org\/10.1002\/ijc.11292.","journal-title":"Int J Cancer"},{"issue":"8","key":"3684_CR12","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1158\/1078-0432.Ccr-05-2552","volume":"12","author":"D Steinbach","year":"2006","unstructured":"Steinbach D, Schramm A, Eggert A, Onda M, Dawczynski K, Rump A, et al. Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia. Clin Cancer Res: An Off J Am Assoc Cancer Res. 2006;12(8):2434\u201341. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-05-2552.","journal-title":"Clin Cancer Res: An Off J Am Assoc Cancer Res"},{"key":"3684_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092512","author":"M Coan","year":"2018","unstructured":"Coan M, Rampioni Vinciguerra GL, Cesaratto L, Gardenal E, Bianchet R, Dassi E, et al. Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer. Int Journal of Molecular Sciences. 2018. https:\/\/doi.org\/10.3390\/ijms19092512.","journal-title":"Int Journal of Molecular Sciences."},{"issue":"1","key":"3684_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3892\/ol.2021.13128","volume":"23","author":"L Ding","year":"2022","unstructured":"Ding L, Luo J, Zhang JP, Wang J, Li ZQ, Huang J, et al. Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR\/ABL1-negative myeloproliferative neoplasms. Oncol Lett. 2022;23(1):10. https:\/\/doi.org\/10.3892\/ol.2021.13128.","journal-title":"Oncol Lett"},{"issue":"5","key":"3684_CR15","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3892\/or.2020.7776","volume":"44","author":"R Zhang","year":"2020","unstructured":"Zhang R, Zhu H, Yuan Y, Wang Y, Tian Z. SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN\/PI3K\/AKT pathway in Burkitt lymphoma. Oncol Rep. 2020;44(5):2021\u201330. https:\/\/doi.org\/10.3892\/or.2020.7776.","journal-title":"Oncol Rep"},{"issue":"5","key":"3684_CR16","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3892\/or.2017.5540","volume":"37","author":"X Li","year":"2017","unstructured":"Li X, Yang B, Wang L, Chen L, Luo X, Liu L. SPAG6 regulates cell apoptosis through the TRAIL signal pathway in myelodysplastic syndromes. Oncol Rep. 2017;37(5):2839\u201346. https:\/\/doi.org\/10.3892\/or.2017.5540.","journal-title":"Oncol Rep"},{"issue":"7391","key":"3684_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603\u20137. https:\/\/doi.org\/10.1038\/nature11003.","journal-title":"Nature"},{"issue":"18","key":"3684_CR18","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1182\/bloodadvances.2021006920","volume":"6","author":"J Mu","year":"2022","unstructured":"Mu J, Yuan P, Luo J, Chen Y, Tian Y, Ding L, et al. Upregulated SPAG6 promotes acute myeloid leukemia progression through MYO1D that regulates the EGFR family expression. Blood Adv. 2022;6(18):5379\u201394. https:\/\/doi.org\/10.1182\/bloodadvances.2021006920.","journal-title":"Blood Adv"},{"issue":"5","key":"3684_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1089\/dna.2018.4521","volume":"38","author":"M Jiang","year":"2019","unstructured":"Jiang M, Chen Y, Deng L, Luo X, Wang L, Liu L. Upregulation of SPAG6 in myelodysplastic syndrome: knockdown inhibits cell proliferation via AKT\/FOXO signaling pathway. DNA Cell Biol. 2019;38(5):476\u201384. https:\/\/doi.org\/10.1089\/dna.2018.4521.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"3684_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3892\/ijo.2018.4390","volume":"53","author":"J Yin","year":"2018","unstructured":"Yin J, Li X, Zhang Z, Luo X, Wang L, Liu L. SPAG6 silencing induces apoptosis in the myelodysplastic syndrome cell line SKM-1 via the PTEN\/PI3K\/AKT signaling pathway in vitro and in vivo. Int J Oncol. 2018;53(1):297\u2013306. https:\/\/doi.org\/10.3892\/ijo.2018.4390.","journal-title":"Int J Oncol"},{"issue":"1","key":"3684_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3892\/ol.2020.11607","volume":"20","author":"M Zhang","year":"2020","unstructured":"Zhang M, Luo J, Luo X, Liu L. SPAG6 silencing induces autophagic cell death in SKM-1 cells via the AMPK\/mTOR\/ULK1 signaling pathway. Oncol Lett. 2020;20(1):551\u201360. https:\/\/doi.org\/10.3892\/ol.2020.11607.","journal-title":"Oncol Lett"},{"issue":"11","key":"3684_CR22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nrc1208","volume":"3","author":"PM Siegel","year":"2003","unstructured":"Siegel PM, Massagu\u00e9 J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer. 2003;3(11):807\u201321. https:\/\/doi.org\/10.1038\/nrc1208.","journal-title":"Nat Rev Cancer"},{"issue":"37","key":"3684_CR23","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1038\/sj.onc.1208923","volume":"24","author":"HK Lin","year":"2005","unstructured":"Lin HK, Bergmann S. Pandolfi pp Deregulated TGF-beta signaling in leukemogenesis. Oncogene. 2005;24(37):5693\u2013700. https:\/\/doi.org\/10.1038\/sj.onc.1208923.","journal-title":"Oncogene"},{"issue":"12","key":"3684_CR24","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1182\/blood-2005-10-4169","volume":"107","author":"M Dong","year":"2006","unstructured":"Dong M, Blobe GC. Role of transforming growth factor-beta in hematologic malignancies. Blood. 2006;107(12):4589\u201396. https:\/\/doi.org\/10.1182\/blood-2005-10-4169.","journal-title":"Blood"},{"key":"3684_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2014.11.001","volume":"147","author":"C Neuzillet","year":"2015","unstructured":"Neuzillet C, Tijeras-Raballand A, Cohen R, Cros J, Faivre S, Raymond E, et al. Targeting the TGF\u03b2 pathway for cancer therapy. Pharmacol Ther. 2015;147:22\u201331. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.001.","journal-title":"Pharmacol Ther"},{"key":"3684_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/587193","volume":"2015","author":"P Papageorgis","year":"2015","unstructured":"Papageorgis P. TGF\u03b2 signaling in tumor initiation, epithelial-to-mesenchymal transition, and metastasis. J oncol. 2015;2015: 587193. https:\/\/doi.org\/10.1155\/2015\/587193.","journal-title":"J oncol"},{"key":"3684_CR27","doi-asserted-by":"publisher","unstructured":"Hematology Oncology Committee, Chinese Anti-Cancer Association; Leukemia & Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association. [Chinese guidelines for diagnosis and treatment of acute lymphoblastic leukemia (2016)]. Zhonghua xue ye xue za zhiZhonghua xueyexue zazhi. 2016;37(10):837\u201345. doi:https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2016.10.002","DOI":"10.3760\/cma.j.issn.0253-2727.2016.10.002"},{"issue":"9","key":"3684_CR28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.6004\/jnccn.2017.0147","volume":"15","author":"PA Brown","year":"2017","unstructured":"Brown PA, Shah B, Fathi A, Wieduwilt M, Advani A, Aoun P, et al. NCCN guidelines insights: acute lymphoblastic leukemia, version 1.2017. J Nat Compr Cancer Network: JNCCN. 2017;15(9):1091\u2013102. https:\/\/doi.org\/10.6004\/jnccn.2017.0147.","journal-title":"J Nat Compr Cancer Network: JNCCN"},{"issue":"6","key":"3684_CR29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1158\/1078-0432.Ccr-14-1999","volume":"21","author":"D Steinbach","year":"2015","unstructured":"Steinbach D, Bader P, Willasch A, Bartholomae S, Debatin KM, Zimmermann M, et al. Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia. Clin Cancer Res: Off J Am Assoc Cancer Res. 2015;21(6):1353\u20139. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-1999.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"issue":"5","key":"3684_CR30","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/leu.2011.307","volume":"26","author":"MA Mulaw","year":"2012","unstructured":"Mulaw MA, Krause A, Deshpande AJ, Krause LF, Rouhi A, La Starza R, et al. CALM\/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12. Leukemia. 2012;26(5):1012\u20139. https:\/\/doi.org\/10.1038\/leu.2011.307.","journal-title":"Leukemia"},{"issue":"12","key":"3684_CR31","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.jmoldx.2021.09.004","volume":"23","author":"AS Skou","year":"2021","unstructured":"Skou AS, Juul-Dam KL, Hansen M, Lausen B, Stratmann S, Holmfeldt L, et al. Measurable residual disease monitoring of SPAG6, ST18, PRAME, and XAGE1A expression in peripheral blood may detect imminent relapse in childhood acute myeloid leukemia. J Mol Diagn: JMD. 2021;23(12):1787\u201399. https:\/\/doi.org\/10.1016\/j.jmoldx.2021.09.004.","journal-title":"J Mol Diagn: JMD"},{"issue":"16","key":"3684_CR32","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541\u201352. https:\/\/doi.org\/10.1056\/NEJMra1400972.","journal-title":"N Engl J Med"},{"issue":"2","key":"3684_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3892\/ijo.2014.2768","volume":"46","author":"B Yang","year":"2015","unstructured":"Yang B, Wang L, Luo X, Chen L, Yang Z, Liu L. SPAG6 silencing inhibits the growth of the malignant myeloid cell lines SKM-1 and K562 via activating p53 and caspase activation-dependent apoptosis. Int J Oncol. 2015;46(2):649\u201356. https:\/\/doi.org\/10.3892\/ijo.2014.2768.","journal-title":"Int J Oncol"},{"issue":"7","key":"3684_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrc1926","volume":"6","author":"B Bierie","year":"2006","unstructured":"Bierie B, Moses HL. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer. 2006;6(7):506\u201320. https:\/\/doi.org\/10.1038\/nrc1926.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3684_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00441-011-1179-5","volume":"347","author":"H Ikushima","year":"2012","unstructured":"Ikushima H, Miyazono K. TGF-\u03b2 signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-\u03b2. Cell Tissue Res. 2012;347(1):37\u201349. https:\/\/doi.org\/10.1007\/s00441-011-1179-5.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"3684_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-001-0479-6","volume":"307","author":"N Schuster","year":"2002","unstructured":"Schuster N, Krieglstein K. Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res. 2002;307(1):1\u201314. https:\/\/doi.org\/10.1007\/s00441-001-0479-6.","journal-title":"Cell Tissue Res"},{"issue":"3","key":"3684_CR37","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1074\/jbc.M808080200","volume":"284","author":"LC Spender","year":"2009","unstructured":"Spender LC, Inman GJ. TGF-beta induces growth arrest in Burkitt lymphoma cells via transcriptional repression of E2F\u20131. J Biol Chem. 2009;284(3):1435\u201342. https:\/\/doi.org\/10.1074\/jbc.M808080200.","journal-title":"J Biol Chem"},{"issue":"Pt 6","key":"3684_CR38","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1099\/0022-1317-81-6-1567","volume":"81","author":"GJ Inman","year":"2000","unstructured":"Inman GJ, Allday MJ. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt\u2019s lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines. J Gen Virol. 2000;81(Pt 6):1567\u201378. https:\/\/doi.org\/10.1099\/0022-1317-81-6-1567.","journal-title":"J Gen Virol"},{"key":"3684_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a027987","author":"K Naka","year":"2017","unstructured":"Naka K, Hirao A. Regulation of Hematopoiesis and Hematological Disease by TGF-\u03b2 Family Signaling Molecules. Cold Spring Harbor Perspect Biol. 2017. https:\/\/doi.org\/10.1101\/cshperspect.a027987.","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"4","key":"3684_CR40","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1172\/jci36428","volume":"119","author":"AM Ford","year":"2009","unstructured":"Ford AM, Palmi C, Bueno C, Hong D, Cardus P, Knight D, et al. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. J Clin Investig. 2009;119(4):826\u201336. https:\/\/doi.org\/10.1172\/jci36428.","journal-title":"J Clin Investig"},{"issue":"6","key":"3684_CR41","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa031197","volume":"351","author":"LA Wolfraim","year":"2004","unstructured":"Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE, et al. Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med. 2004;351(6):552\u20139. https:\/\/doi.org\/10.1056\/NEJMoa031197.","journal-title":"N Engl J Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03684-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03684-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03684-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T14:33:43Z","timestamp":1706711623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03684-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["3684"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03684-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,26]]},"assertion":[{"value":"10 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The use of bone marrow specimens was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (Approval No. 2022-K289; Chongqing, China), and written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}